Stay updated on Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision number changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:31:04.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T22:43:09.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the previously visible study record details with a basic error layout and a Home link. This indicates the page is inaccessible.
    Difference
    18%
    Check dated 2026-09-22T23:33:22.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision tag updated to v3.7.0, replacing v3.6.6. This reflects a metadata/templating update and does not modify the AMEERA-5 study content or results.
    Difference
    0.0%
    Check dated 2026-09-15T22:27:07.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page shows an updated revision number (v3.6.6) compared with the prior version, indicating a deployment or template update rather than changes to the study details or results.
    Difference
    0.0%
    Check dated 2026-09-01T18:32:41.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Page revision updated to v3.6.5. The items EFC15935 Plain Language Results Summary, Sanofi, and Helpful Links Provided by were removed.
    Difference
    0.1%
    Check dated 2026-08-11T20:19:28.000Z thumbnail image

Stay in the know with updates to Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.